• Gastrointestinal System Agents, Hyoscine
    Dosage form: Tablet
    Strength: 10mg
    Indications/Special comments: Prevention of motion sickness. Prevention of postoperative nausea and vomiting. Oral: Symptomatic treatment of postencephalitis Parkinsonism and paralysis agitans. Treatment of spasticity. Inhibits excessive motility and hypertonus of GI tract in irritable colon syndrome, mild dysentery, diverticulitis, and pylorospasm. Prevention of motion sickness.
    Dosage Administration: Adults: 0.4 – 0.8mg; may repeat every 8 – 12 hr as needed (dose may be increased in Parkinsonism and spastic states); for motion sickness, give at least 1 hr before exposure to motion.
    View full drug info
  • Drugs for Correcting Water Electrolyte and Acidbase Disturbances, Human Milk Fortifier
    Dosage form: Suspension
    Strength: 24 cal/30ml
    Indications/Special comments: Intended for low-birth-weight infants as a nutritional supplement to add to preterm human milk
    Dosage Administration: As directed by physician on advice of the dietician.
    View full drug info
  • Corticosteroidal Preparations, Hydrocortisone
    Dosage form: Tablet
    Strength: 10mg
    Indications/Special comments: Adrenocortical insufficiency; hypersensitivity reactions including anaphylactic shock inflammatory bowel disease.
    Dosage Administration: Replacement therapy in adrenocortical insufficiency: Adult: 20 - 30mg daily in divided doses (usually 20mg in the morning and 10mg in early evening); Child: 10 - 30mg
    View full drug info
  • Corticosteroidal Preparations, Hydrocortisone
    Dosage form: Powder for Injection
    Strength: 100mg, 250mg, 500mg
    Indications/Special comments: Adrenocortical insufficiency; hypersensitivity reactions including anaphylactic shock inflammatory bowel disease.
    Dosage Administration: Acute adrenocortical insufficiency: Slow IV injection or IV infusion: Adult: 100 – 500mg, 3 - 4 times in 24 hours or as required; Slow IV injection: Child up to 1 year: 25mg; Child 1 - 5 years: 50mg; Child 6 - 12 years: 100mg.
    View full drug info
  • Cardiovascular Drugs, Hydrochlorothiazide + Spironolactone
    Dosage form: Tablet
    Strength: 25mg + 25mg; 50mg + 50mg
    Indications/Special comments: Oedematous conditions for patients with Congestive heart failure; cirrhosis of the liver accompanied by oedema and/or ascites; the nephrotic syndrome; essential hypertension:
    Dosage Administration: Oedema in Adults (Congestive Heart Failure, Hepatic Cirrhosis or Nephrotic Syndrome): The usual maintenance dose is 100mg each of Spironolactone and Hydrochlorothiazide daily, administered in a single dose or in divided doses, but may range from 25mg to 200mg of each component daily depending on the response to the initial titration. Essential Hypertension: Although the dosage will vary depending on the results of titration of the individual ingredients, many patients will be found to have an optimal response to 50mg to 100mg each of Spironolactone and Hydrochlorothiazide daily, given in a single dose or in divided doses. Concurrent potassium supplementation is not recommended when Spironolactone and Hydrochlorothiazide tablets are used in the long-term management of hypertension or in the treatment of most oedematous conditions, since the spironolactone content of Spironolactone and Hydrochlorothiazide tablets is usually sufficient to minimize loss induced by the hydrochlorothiazide component.
    View full drug info
  • Cardiovascular Drugs, Hydrochlorothiazide
    Dosage form: Tablet
    Strength: 25mg
    Indications/Special comments: Oedema, hypertension and cardiac failure.
    Dosage Administration: Hypertension: Adult: 12.5, 25mg daily; elderly, initially 12.5mg daily. Oedema: Adult: initially, 25mg daily on rising increasing to 50mg daily if necessary, elderly initially 12.5mg daily. Severe oedema in patients unable to tolerate loop diuretics: Adult: up to 100mg either daily or on alternate days (maximum 100 mg daily). Nephrogenic diabetes insipidus: Adult: initially up to 100mg daily.
    View full drug info
  • Cardiovascular Drugs, Hydralazine
    Dosage form: Tablet
    Strength: 25mg, 50mg
    Indications/Special comments: Moderate to severe hypertension (low doses used in combination therapy, especially with beta blockers).
    Dosage Administration: Hypertension: 25mg twice daily, increased to a maximum of 50mg twice daily.
    View full drug info
  • Cardiovascular Drugs, Hydralazine
    Dosage form: Injection
    Strength: 20mg/ml
    Indications/Special comments: Moderate to severe hypertension (low doses used in combination therapy, especially with beta blockers).
    Dosage Administration: Hypertensive crisis: slow IV injection: 5 - 10mg over 20 minutes; may be repeated after 20 - 30 minutes. IV infusion: initially 200 - 300 microgram/minute. Maintenance usually 50 - 150 mcg/minute.
    View full drug info
  • Blood products and drugs affecting blood, Human Factor VIII Fraction
    Dosage form: Injection
    Strength: 25 IU/ml
    Indications/Special comments: Management of Haemophilia A associated with a deficiency of factor VIII. Management of von Willebrand's disease that has not responded adequately to desmopressin. Prevention of excessive bleeding during and after surgery in patients with severe von Willebrand's disease. Routine prevention to decrease bleeding and risk of joint damage in children with haemophilia A who have no pre-existing joint damage. Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with Haemophilia A.
    Dosage Administration: Consult individual product information for more specific dosing information.
    View full drug info
  • Blood products and drugs affecting blood, Heparin Sodium
    Dosage form: Injection
    Strength: 1000 units/ml; 10,000 units/ml
    Indications/Special comments: Treatment and prophylaxis of deep-vein thrombosis and pulmonary embolism.
    Dosage Administration: Treatment of deep-vein thrombosis and pulmonary embolism: Adult: IV injection, loading dose of 5000 units (10,000 units in severe cases) followed by continuous intravenous infusion of 15 – 25 units/kg/hour or by SC injection of 15000 units every 12 hours. Child: lower loading dose, then by continuous IV infusion, 15 – 25 units/kg/hour or by SC, 250 units /kg every 12 hours. Prophylaxis in general surgery: Adult: SC: 5000 units 2 hours before surgery, then every 8 - 12 hours for 7 days or until patient is ambulant.
    View full drug info